Oncology Companion Diagnostic Market Revenue was valued at USD 12.5 Billion in 2024 and is estimated to reach USD 25.8 Billion by 2033, growing at a CAGR of 9.5% from 2026 to 2033.
The global oncology companion diagnostic market was valued at USD 7.8 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030. The increasing demand for personalized medicine, advancements in molecular biology, and the growing prevalence of cancer are expected to drive market growth during the forecast period. North America held the largest market share in 2022, contributing approximately 45% of the total market revenue. This can be attributed to the presence of well established healthcare infrastructure, high adoption rates of advanced diagnostic technologies, and ongoing research activities in the region. Additionally, Europe accounted for a significant portion of the market, with an estimated share of 30%, driven by strong government initiatives and high healthcare expenditure in countries such as Germany, France, and the UK. In the Asia Pacific region, the oncology companion diagnostic market is anticipated to experience rapid growth, with a CAGR of 12.3% during the forecast period. This is primarily due to the rising cancer incidences, increasing healthcare investments, and improving access to advanced medical technologies in countries such as China, Japan, and India. The Latin American and Middle East & Africa regions are expected to contribute moderately to the overall market growth, with rising awareness, healthcare reforms, and a growing focus on oncology treatments. These regions are projected to see a CAGR of 9.7% and 8.3%, respectively, from 2023 to 2030, offering substantial opportunities for market players to expand their reach and improve healthcare outcomes through precision medicine and diagnostics.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=390252&utm_source=Pulse_G_April&utm_medium=212
Agilent Technologies
Inc.
Illumina
Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
ARUP Laboratories
Abbott
Myriad Genetics
Inc.
bioMérieux SA
Invivoscribe
Inc.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=390252&utm_source=Pulse_G_April&utm_medium=212
Growing demand for below applications around the world has had a direct impact on the growth of the Global Oncology Companion Diagnostic Market
Laboratory Developed Tests (LDTs)
In Vitro Diagnostic Tests (IVDs)
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
In Situ Hybridization (ISH)
Immunohistochemistry (IHC)
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Leukemia
Other Cancers
HER2
EGFR
KRAS
ALK
BRCA
PD-L1
Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical Companies
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/oncology-companion-diagnostic-market/
1. Introduction of the Global Oncology Companion Diagnostic Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Oncology Companion Diagnostic Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Oncology Companion Diagnostic Market, By Type
6. Global Oncology Companion Diagnostic Market, By Application
7. Global Oncology Companion Diagnostic Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Oncology Companion Diagnostic Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/